Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of L...( Collaboration Will Seek to Identify...),Health

Collaboration Will Seek to Identify Unique microRNA Signatures That Will

Predict Risk of Recurrence in Lung Cancer Patients The Project Will Leverage Rosetta Genomics' Proprietary microRNA Extraction and Quantification Technologies, and M. D. Anderson's Extensive Know-How

and Experience in Lung Cancer Research Test Will be Designed to Assist in Distinguishing Patients With High Risk of Recurrence, who may Benefit From Adjuvant or Targeted Therapies, From

Those With Low Risk

REHOVOT, Israel and JERSEY CITY, New Jersey, June 6 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced today a research collaboration with The University of Texas M. D. Anderson Cancer Center and the Kleberg Center for Molecular Markers to develop a microRNA- based diagnostic test to predict risk of disease recurrence in lung cancer patients who have undergone curative resection.

Current treatment for lung cancer includes surgical resection which may be followed by adjuvant therapy. While patients with high risk of recurrence may benefit from adjuvant therapy, those with low risk of recurrence may be exposed to unnecessary toxicities. The goal of this collaboration is to develop a test that will enable physicians to distinguish between patients with high and low risk of recurrence to optimize treatment regimens.

"The potential diagnostic applications of microRNA biomarkers are broad and diverse," noted Amir Avniel, president and CEO of Rosetta Genomics. "We are very pleased to be collaborating with M. (space) D. Anderson, one of the world's leading cancer research centers, on this important project in lung cancer. We believe that the experience we have in working with microRNA biomarkers, combined with M. (space) D. Anderson's extensive experience in lung cancer research, makes this a strong colla
'/>"/>